Yan et al. [82] demonstrated that hepatocellular carcinoma cells (HepG2) exhibited a decreased Bcl-2/Bax ratio after CAP treatment, inducing apoptosis. The gene discussed is BCL2; the disease is hepatocellular carcinoma.